Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Cited by (475)

Items 201–300 of 475

1. Structural insights into the agonist selectivity of the adenosine A3 receptor
   Hidetaka S. Oshima, Akiko Ogawa, Fumiya K. Sano, Hiroaki Akasaka, Tomoyoshi Kawakami, Aika Iwama, Hiroyuki H. Okamoto, Chisae Nagiri, Fan‐Yan Wei, Wataru Shihoya et al. · 2024 · Nature Communications
2. Six-Step Synthesis of (±)-Lysergic Acid
   Brian J. Knight, Ryan C. Harbit, Joel M. Smith · 2023 · The Journal of Organic Chemistry
3. Synthetic surprise as the foundation of the psychedelic experience
   Roberto De Filippo, Dietmar Schmitz · 2024 · Neuroscience & Biobehavioral Reviews
4. Psychedelic compounds directly excite 5-HT 2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT 2A Gq -mediated activation mechanism
   Gavin P. Schmitz, Yi-Ting Chiu, Gabriele Maria König, Evi Kostenis, Bryan L. Roth, Melissa A. Herman · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
5. Structure and dynamics of the pyroglutamylated RF-amide peptide QRFP receptor GPR103
   Iwama, Aika, Kise, Ryoji, Akasaka, Hiroaki, Sano, Fumiya K., Oshima, Hidetaka S., Inoue, Asuka, Shihoya, Wataru, Nureki, Osamu · 2024 · Nature Communications
6. Intracellular GPCR modulators enable precision pharmacology
   Brian E. Krumm, Bryan L. Roth · 2025 · npj Drug Discovery.
7. Insights into G-protein coupling preference from cryo-EM structures of Gq-bound PTH1R
   Fumiya K. Sano, Kota Shimizume, Kazuhiro Kobayashi, Toshikuni Awazu, Kouki Kawakami, Hiroaki Akasaka, Takaaki A. Kobayashi, Tatsuki Tanaka, Hiroyuki H. Okamoto, Hisato Hirano et al. · 2025 · Nature Chemical Biology
8. Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology
   Michał K. Jastrzębski, Piotr Wójcik, Angelika Grudzińska, Giorgia Andreozzi, Tommaso Vetrò, A Asim, Akanksha Mudgal, Jakub Czapiński, Tomasz M. Wróbel, Damian Bartuzi et al. · 2025 · Acta Pharmaceutica Sinica B
9. Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis
   C Pushpaveni, S Hemavathi, Santosh Prasad Chaudhary Kurmi, Biswa Ranjan Patra, V Angelin Esther, Chandrajeet Kumar Yadav, Mahalakshmi Suresha Biradar, Shankar Thapa · 2025 · Bioinformatics and Biology Insights
10. The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice
    Sixtine Fleury, Katherine M. Nautiyal · 2025 · Molecular Psychiatry
11. μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
    Leah M. Salinsky, Christina R. Merritt, Joshua C. Zamora, Juliana L. Giacomini, Noelle C. Anastasio, Kathryn A. Cunningham · 2023 · Frontiers in Pharmacology
12. Molecular glues as potential GPCR therapeutics
    Bryan L. Roth, Brian E. Krumm · 2024 · Biochemical Pharmacology
13. Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy- N , N -dimethyltryptamine Analogs in Mice
    Grant C. Glatfelter, Allison A. Clark, Natalie G. Cavalco, Antonio Landavazo, John S. Partilla, Marilyn Naeem, James A. Golen, A.R. Chadeayne, David R. Manke, Bruce E. Blough et al. · 2024 · ACS Chemical Neuroscience
14. Non-hallucinogenic Psychedelic Analog Design: A Promising Direction for Depression Treatment
    Yanan Yin, Tianming Gao · 2022 · Neuroscience Bulletin
15. SnapShot: Psychedelics and serotonin receptor signaling
    Ryan H. Gumpper, Bryan L. Roth · 2023 · Cell
16. Constitutive activation mechanism of a class C GPCR
    Jin Woo Shin, Junhyeon Park, Jieun Jeong, Jordy Homing Lam, Xingyu Qiu, Di Wu, Kuglae Kim, Joo‐Youn Lee, Carol V. Robinson, Jaekyung Hyun et al. · 2024 · Nature Structural & Molecular Biology
17. Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial
    Vanderijst, Laetitia, Hever, Felix, Buot, Anne, Dauré, Charles, Benoit, Janaïna, Hanak, Catherine, Veeser, Johannes, Morgiève, Margot, Campanella, Salvatore, Kornreich, Charles et al. · 2024 · BMC Psychiatry
18. Ligand recognition and activation of neuromedin U receptor 2
    Wenli Zhao, Wenru Zhang, Mu Wang, Minmin Lu, Shutian Chen, Tingting Tang, Gisela Schnapp, Holger Wagner, Albert Brennauer, Cuiying Yi et al. · 2022 · Nature Communications
19. G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics
    Gavin P. Schmitz, Bryan L. Roth · 2023 · American Journal of Physiology-Cell Physiology
20. Chemistry/structural biology of psychedelic drugs and their receptor(s)
    Ryan H. Gumpper, David E. Nichols · 2024 · British Journal of Pharmacology
21. Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice
    Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland, John S. Partilla, Michael H. Baumann, Grant C. Glatfelter · 2025 · Psychopharmacology
22. Psychedelic neuroplasticity of cortical neurons lacking 5-HT2A receptors
    Tyler G. Ekins, Chloe Rybicki-Kler, Tao Deng, Isla A. W. Brooks, Izabela Jedrasiak‐Cape, Ethan Donoho, Omar J. Ahmed · 2025 · Molecular Psychiatry
23. MD Simulations Revealing Special Activation Mechanism of Cannabinoid Receptor 1
    Yiran Wu, Xuanxuan Li, Tian Hua, Zhi‐Jie Liu, Haiguang Liu, Suwen Zhao · 2022 · Frontiers in Molecular Biosciences
24. A new class of 5‐HT2A/5‐HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins
    Austen B. Casey, Munmun Mukherjee, Ryan P. McGlynn, Meng Cui, Stephen John Kohut, Raymond G. Booth · 2021 · British Journal of Pharmacology
25. Cryo-EM reveals an extrahelical allosteric binding site at the M5 mAChR
    Wessel A. C. Burger, Jesse I. Mobbs, Bhavika Rana, Jinan Wang, Keya Joshi, Patrick R. Gentry, Mahmuda Yeasmin, Hariprasad Venugopal, Aaron M. Bender, Craig W. Lindsley et al. · 2025 · Nature Communications
26. Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
    Fan Yang, Huanhuan Zhang, Xianyu Meng, Yingge Li, Yingxin Zhou, Shenglong Ling, Demeng Sun, Pei Lv, Lei Liu, Pan Shi et al. · 2022 · Cell Research
27. Structural basis for ligand recognition and activation of the prostanoid receptors
    Xiu Li, Xuan Zhang, Xin Wen, Daolai Zhang, Changxiu Qu, Xinyi Miao, Wenkai Zhang, Ru Zhang, Guibing Liu, Peng Xiao et al. · 2024 · Cell Reports
28. The structural basis of the G protein–coupled receptor and ion channel axis
    Yulin Luo, Liping Sun, Yao Peng · 2025 · Current Research in Structural Biology
29. Psilocybin as Transformative Fast‐Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms
    Makiath Adebo, Mathilda Bonnet, Ons Laouej, Céline Defaix, Josephine Cecelia McGowan, Florence Butlen‐Ducuing, Denis Joseph Paul David, Erwan Poupon, Laurent Tritschler, Alain Michel Gardier · 2025 · Fundamental and Clinical Pharmacology
30. Identification of Potential Parkinson’s Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network
    Jie Liu, Dongdong Peng, Jinlong Li, Zong Dai, Xiaoyong Zou, Zhanchao Li · 2022 · Molecules
31. Structural insights into constitutive activity of 5-HT 6 receptor
    Licong He, Qiaoyu Zhao, Jianzhong Qi, Yifan Wang, Wenyu Han, Zhangcheng Chen, Yao Cong, Sheng Wang · 2023 · Proceedings of the National Academy of Sciences
32. Design, Synthesis, Molecular Docking, and Biological Evaluation of Novel Pimavanserin-Based Analogues as Potential Serotonin 5-HT2A Receptor Inverse Agonists
    Nader R. Albujuq, J. Javier Meana, Rebeca Dı́ez-Alarcia, Itziar Muneta Arrate, Arshi Naqvi, Khalid Althumayri, Mosa Alsehli · 2023 · Journal of Medicinal Chemistry
33. Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders
    Maleesha Ubhayarathna, Christopher J. Langmead, Natalie A. Diepenhorst, Gregory D. Stewart · 2023 · British Journal of Pharmacology
34. Multi-effective components and their target mechanism of Ziziphi Spinosae Semen in the treatment of insomnia
    Xinwei Zhao, Tao Hou, Han Zhou, Ziling Liu, Yanfang Liu, Chaoran Wang, Zhimou Guo, Dongping Yu, Qing Xu, Jixia Wang et al. · 2023 · Fitoterapia
35. The Promise of Psychedelic Science
    David E. Olson · 2021 · ACS Pharmacology & Translational Science
36. Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand specificity and how binding affects the G-protein interface
    Yunseok Heo, Naito Ishimoto, Ye-Eun Jeon, Ji-Hye Yun, Mio Ohki, Yuki Anraku, Mina Sasaki, Shunsuke Kita, Hideo Fukuhara, Tatsuya Ikuta et al. · 2022 · PLoS Biology
37. Molecular insights into GPCR mechanisms for drugs of abuse
    Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, Daniel Wacker · 2023 · Journal of Biological Chemistry
38. Structural basis of psychedelic LSD recognition at dopamine D1 receptor
    Luyu Fan, Youwen Zhuang, Hongyu Wu, Huiqiong Li, Youwei Xu, Yue Wang, Licong He, Shishan Wang, Zhangcheng Chen, Jianjun Cheng et al. · 2024 · Neuron
39. Structural determinants of G protein subtype selectivity at the serotonin receptor 5-HT1A
    Audrey L. Warren, Gregory Zilberg, Anwar Abbassi, Alejandro Abraham, Shifan Yang, Daniel Wacker · 2025 · Science Advances
40. Azepine-Indole Alkaloids From Psychotria nemorosa Modulate 5-HT2A Receptors and Prevent in vivo Protein Toxicity in Transgenic Caenorhabditis elegans
    Benjamin Kirchweger, Luiz Carlos Klein‐Júnior, Dagmar Pretsch, Ya Chen, Sylvian Cretton, André Luís de Gasper, Yvan Vander Heyden, Philippe Christen, Johannes Kirchmair, Amélia Teresinha Henriques et al. · 2022 · Frontiers in Neuroscience
41. A new serotonin 2A receptor antagonist with potential benefits in Non-Alcoholic Fatty Liver Disease
    Lucia Sessa, Simona Concilio, Jesús M. Fominaya, Daniela Eletto, Stefano Piotto, Xavier Busquets · 2022 · Life Sciences
42. Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
    Hanbo Yao, Xiaodong Wang, Jiaxin Chi, Haorong Chen, Yilin Liu, Yang Jiayi, Jiaqi Yu, Yongdui Ruan, Xufu Xiang, Jiang Pi et al. · 2024 · Molecules
43. Potential Serotonin 5-HT2A Receptor Agonist of Psychoactive Components of Silene undulata Aiton: LC-MS/MS, ADMET, and Molecular Docking Studies
    Maram B. Alhawarri, Suleiman Olimat · 2024 · Current Pharmaceutical Biotechnology
44. Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist
    Geoffrey B. Varty, Clinton Ernest Canal, Tina A. Mueller, Joshua A. Hartsel, Richa Tyagi, Ken Avery, Michael E. Morgan, Amy Claire Reichelt, Pradip Pathare, Erik M. Stang et al. · 2024 · Journal of Medicinal Chemistry
45. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa
    Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire · 2021 · OBM Neurobiology
46. Environment-Sensitive Fluorescence of 7-Nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-Labeled Ligands for Serotonin Receptors
    Parijat Sarkar, Kaleeckal G. Harikumar, Satinder S. Rawat, Sanjib Das, Tushar Kanti Chakraborty, Amitabha Chattopadhyay · 2021 · Molecules
47. Age- and estrous-dependent effects of psilocybin in rats
    Alexia L. Zylko, Ryan J. Rakoczy, B.F. Roberts, M. Wilson, A. Powell, A. Page, M. Heitkamp, D. Feist, J. Andrew Jones, Matthew Stephen McMurray · 2025 · Neuropharmacology
48. Specific Engineered G Protein Coupling to Histamine Receptors Revealed from Cellular Assay Experiments and Accelerated Molecular Dynamics Simulations
    Carina Höring, Marcus Conrad, Christian A. Söldner, Jinan Wang, Heinrich Sticht, Andrea Straßer, Yinglong Miao · 2021 · International Journal of Molecular Sciences
49. In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice
    Dorota Nieoczym, Nancy Saana Banono, Katarzyna E. Stępnik, Agnieszka Anna Kaczor, Przemysław Szybkowski, Camila Vicencio Esguerra, Wirginia Anna Kukula-Koch, Kinga Gaweł · 2023 · International Journal of Molecular Sciences
50. Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα
    Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia · 2025 · FEBS Letters
51. Living-Cell Diffracted X-ray Tracking Analysis Confirmed Internal Salt Bridge Is Critical for Ligand-Induced Twisting Motion of Serotonin Receptors
    Kazuhiro Mio, Shoko Fujimura, Masaki Ishihara, Masahiro Kuramochi, Hiroshi Sekiguchi, Tai Kubo, Yuji C. Sasaki · 2021 · International Journal of Molecular Sciences
52. Cholesterol footprint in high-resolution structures of serotonin receptors: Where are we now and what does it mean?
    Parijat Sarkar, Amitabha Chattopadhyay · 2021 · Chemistry and Physics of Lipids
53. Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics
    Wolfgang Sadée · 2023 · Molecules
54. Molecular Dynamics (MD) Simulations Provide Insights into the Activation Mechanisms of 5-HT2A Receptors
    Meng Cui, Yongcheng Lu, Mihaly Mezei, Diomedes E. Logothetis · 2024 · Molecules
55. High-affinity agonists reveal recognition motifs for the MRGPRD GPCR
    Chunyu Wang, Yongfeng Liu, Marion C. Lanier, Adam R. Yeager, Isha Singh, Ryan H. Gumpper, Brian E. Krumm, Chelsea DeLeon, Shicheng Zhang, Marcus F. Boehm et al. · 2024 · Cell Reports
56. The ABCs of psychedelics: a preclinical roadmap for drug discovery
    Alex C. Kwan, John R. Mantsch, John D. McCorvy · 2025 · Trends in Pharmacological Sciences
57. Evolutionary association of receptor-wide amino acids with G protein–coupling selectivity in aminergic GPCRs
    Berkay Selçuk, İsmail Erol, Serdar Durdağı, Ogün Adebalı · 2022 · Life Science Alliance
58. 6-Gingerol, a major ingredient of ginger, attenuated cisplatin-induced pica in rats via regulating 5-HT3R/Ca2+/CaMKII/ERK1/2 signaling pathway
    Ziyao Mo, Yihong Xian, Ruifang Zhang, Yongzhao Dai, Weijian Chen, Ke Nie · 2022 · Journal of Functional Foods
59. A Novel “Activation Switch” Motif Common to All Aminergic Receptors
    Kuo Hao Lee, Jamie J. Manning, Jonathan A. Javitch, Lei Shi · 2023 · Journal of Chemical Information and Modeling
60. Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
    Priyanshu Raj, Shyambabu P. Rauniyar, Bhagyesh Sapkale · 2023 · Cureus
61. Photoswitchable Serotonins for Optical Control of the 5‐HT 2A Receptor**
    Johannes Morstein, Giovanna R. Romano, Belinda E. Hetzler, Ambrose Plante, Caleb Haake, Joshua Levitz, Dirk H. Trauner · 2022 · Angewandte Chemie
62. A unified analysis of evolutionary and population constraint in protein domains highlights structural features and pathogenic sites
    MacGowan, Stuart A., Madeira, Fábio, Britto-Borges, Thiago, Barton, Geoffrey J. · 2024 · Communications Biology
63. Structural insights into the activation of the human prostaglandin E 2 receptor EP1 subtype by prostaglandin E 2
    Xue Zheng Meng, Yang Li, Jiuyin Xu, Kai Wu, Wen Hu, Canrong Wu, H. Eric Xu, Youwei Xu · 2025 · Proceedings of the National Academy of Sciences
64. The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
    Dongsun Park, Gwangho Lee, Won-Gyu Lee, B.S. Kim, Yoonji Lee, Ji‐Woon Kim · 2025 · Molecular Psychiatry
65. Biased Signaling in Psychedelic Action
    Daniel Wacker, John D. McCorvy · 2025 · The Annual Review of Pharmacology and Toxicology
66. The dynamic basis of G-protein recognition and activation by a GPCR
    Kazuhiro Kobayashi, Kouki Kawakami, Toshiki E. Matsui, Shun Yokoi, Masahiro Fukuda, Tomohiro J. Narita, Hiroki Arai, Mai Tambo, Takashi Sumikama, Manae Tatsumi et al. · 2026 · Nature
67. Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties
    Margherita Mastromarino, Mauro Niso, Carmen Abate, Ewgenij Proschak, Mariam Dubiel, Holger Stark, Marián Castro, Enza Lacivita, Marcello Leopoldo · 2022 · Molecules
68. Analysis of the Dynamics of the Human Growth Hormone Secretagogue Receptor Reveals Insights into the Energy Landscape of the Molecule
    Albert A. Smith, Emelyne M. Pacull, Sabrina Stecher, Peter Werner Hildebrand, Alexander Vogel, Daniel Huster · 2023 · Angewandte Chemie International Edition
69. Cortical structural differences following repeated ayahuasca use hold molecular signatures
    Pablo Mallaroni, Natasha Leigh Mason, Lilian Kloft, Johannes T. Reckweg, Kim I. M. van Oorsouw, Johannes Gerardus Ramaekers · 2023 · Frontiers in Neuroscience
70. Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT 1e R and 5-HT 1F R
    Gregory Zilberg, Alexandra Kalia Parpounas, Audrey L. Warren, Bianca Fiorillo, Davide Provasi, Marta Filizola, Daniel Wacker · 2024 · Science Advances
71. Structural basis for recognition of 26RFa by the pyroglutamylated RFamide peptide receptor
    Sanshan Jin, Shimeng Guo, Youwei Xu, Xin Li, Canrong Wu, Xinheng He, Benxun Pan, Wenwen Xin, Heng Zhang, Wen Hu et al. · 2024 · Cell Discovery
72. The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex
    Zi-Hang Tang, Zhipeng Yu, Qiong Li, Xiaoqin Zhang, Kadeliya Muhetaer, Zhengchun Wang, Peng Xu, Haowei Shen · 2023 · Psychopharmacology
73. Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
    Alessandro Nicoli, Verena Weber, Carlotta Bon, Alexandra Steuer, Stefano Gustincich, Raul R. Gainetdinov, Roman Lang, Stefano Espinoza, Antonella Di Pizio · 2023 · Journal of Chemical Information and Modeling
74. Use of the head-twitch response to investigate the structure–activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines
    Adam L. Halberstadt, Dino Luethi, Marius Christian Hoener, Daniel Trachsel, Simon D. Brandt, Matthias E. Liechti · 2022 · Psychopharmacology
75. Structure basis of ligand recognition and activation of GPR55
    Hao Chang, Xiaoting Li, Ling Shen, Xuanrui Ge, Shuming Hao, Lijie Wu, Shenhui Liu, Junlin Liu, Vadim Cherezov, Tian Hua · 2024 · Cell Research
76. Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB1 and Serotonin 5HT2A Receptors
    Minos–Timotheos Matsoukas, Marc Ciruela-Jardí, Maria Gallo, Sergi Ferré, David Andreu, Vicent Casadó, Leonardo Pardo, Estefanía Moreno · 2024 · Journal of Medicinal Chemistry
77. Discovery of Highly Potent Serotonin 5-HT2 Receptor Agonists Inspired by Heteroyohimbine Natural Products
    Meghan J. Orr, Andrew B. Cao, Charles Tiancheng Wang, Arsen M. Gaisin, Adam Csakai, Alec P. Friswold, Herbert Y. Meltzer, John D. McCorvy, Karl A. Scheidt · 2022 · ACS Medicinal Chemistry Letters
78. Protein Design Strategies for the Structural–Functional Studies of G Protein-Coupled Receptors
    Daria A. Dmitrieva, Tatiana V. Kotova, Nadezhda A. Safronova, Alexandra A. Sadova, Dmitrii E. Dashevskii, Alexey Mishin · 2023 · Biochemistry (Moscow)
79. Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) Positional Isomers
    Eline Pottie, Olga V. Kupriyanova, Vadim A. Shevyrin, Christophe Pol Stove · 2021 · ACS Chemical Neuroscience
80. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
    Teresa Reynolds de Sousa, João Rema, Sergio Eduardo de Carvalho Machado, Filipa Novais · 2021 · Current Topics in Medicinal Chemistry
81. Ligand-Dependent Modulation of the Dynamics of Intracellular Loops Dictates Functional Selectivity of 5-HT2AR
    Sukanya Mozumder, Aritra Bej, Jayati Sengupta · 2022 · Journal of Chemical Information and Modeling
82. Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond
    Saghir Ali, Xiaochen Tian, Kathryn A. Cunningham, Jia Zhou · 2025 · Journal of Medicinal Chemistry
83. Design, Synthesis, and In Vitro Characterization of a Tryptamine-Based Visible-Light Photoswitchable 5-HT 2A R Ligand Showing Efficacy Preference for β-Arrestin over Mini-Gq
    Alexandra Sink, Eline Pottie, Samuel J. Carter, Robert J. Tombari, Verena Weber, Paolo Carloni, Giulia Rossetti, David E. Olson, Christophe Pol Stove, Michael W. Decker · 2025 · Journal of Medicinal Chemistry
84. Exploring the therapeutic potential of psychedelics in treating substance use disorders
    Y Li, Hongyuan Li, Hongshuang Wang, Xiaohui Wang · 2025 · Molecular Psychiatry
85. Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity
    Alina Vo Vo, Arnab Modak, Sumin Lu, Scott C. Blanchard, Nevin A. Lambert, Michael J. Robertson · 2026 · Nature
86. Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression
    Yulin Zhao, Jinxia Wan, Yulong Li · 2024 · Journal of Neurochemistry
87. Human pluripotent stem cells as a translational toolkit in psychedelic research in vitro
    José Alexandre Salerno, Stevens Kastrup Rehen · 2024 · iScience
88. Effects of an external static EF on the conformational transition of 5-HT1A receptor: A molecular dynamics simulation study
    Lulu Guan, Jingwang Tan, Bote Qi, Yukang Chen, Meng Cao, Qingwen Zhang, Yu Feng Zou · 2024 · Biophysical Chemistry
89. Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects
    Adam J. Drewko, Ron L. P. Habets, Tibor M. Brunt · 2025 · Molecular Psychiatry
90. 5-HT2 Receptor Subfamily and the Halogen Bond Promise
    Angélica Fierro, Douglas J. Matthies, Bruce K. Cassels, Pablo Jaque, Gerald Zapata‐Torres · 2021 · Journal of Chemical Information and Modeling
91. Mechanism of action of antidepressants
    Kuldeepak Sharma, Ankush Sundriyal, Aanchal Loshali, Mohit Agrawal, Chinnabonia Gopala Krishna, Yogendra Prasad Singh · 2022 · Elsevier eBooks
92. Molecular Docking Assessment of Cathinones as 5-HT2AR Ligands: Developing of Predictive Structure-Based Bioactive Conformations and Three-Dimensional Structure-Activity Relationships Models for Future Recognition of Abuse Drugs
    Nevena Tomašević, Maja Vujović, Emilija Kostić, Venkatesan Ragavendran, Biljana B. ARSIC, Sanja Lj. Matić, Mijat Božović, Rossella Fioravanti, Eleonora Proia, Rino Ragno et al. · 2023 · Molecules
93. The molecular basis of the antidepressant action of the magic mushroom extract, psilocin
    Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen, Himanshu Khandelia · 2023 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
94. Biological studies of clavine alkaloids targeting CNS receptors
    Nikhil R. Tasker, Ethan J. Pazur, Peter Wipf · 2023 · Frontiers in Psychiatry
95. LSD’s effects are differentially modulated in arrestin knockout mice
    Ramona M. Rodriguiz, Vineet Nadkarni, Christopher R. Means, Yi-Ting Chiu, Bryan L. Roth, William C. Wetsel · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
96. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.
    Martin G. Myers, C B Toal · 1995 · PubMed
97. Serotonergic modulation of excitatory synapse development and plasticity
    Victoria N. Chang, Roberto Ogelman, Raul Satoshi Vargas, Won Chan Oh · 2026 · Molecules and Cells
98. Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment
    Jun Yang, Ruichao Shen, Chunyu Wang, Wenneng Zhu, Han Ke, Junping Fan, Mengna Zhang, Yingjun Liu, Shuai Li, Guochuan Li et al. · 2026 · Nature Chemical Biology
99. Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)
    Simon D. Brandt, Pierce V. Kavanagh, Sarah Gare, Simon P Elliott, Alexander Stratford, Adam L. Halberstadt · 2024 · Drug Testing and Analysis
100. Impact of G protein-coupled receptor conformation on signaling bias: Integrating simulations and biophysical experiments
     Gian Marco Elisi, Giovanni Bottegoni · 2025 · Pharmacology & Therapeutics